NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary Chapter: 6 - Endocrine system 
Notes:

Any drug not listed on the Formulary should be considered Non-Formulary - Not recommended for prescribing

06.07.02 Drugs affecting gonadotrophins
06.07.02 Gonadorelin analogues

Gonadorelins
(Paediatric use)

RED
Formulary

NHS England do not recommend the use of gonadorelin analogues in children and young people for gender dysphoria. See link for further information.

 All other uses in paediatrics - Red, specialist only.

 

Entry reviewed: April 2024

 

 

Goserelin (Zoladex®, Zoladex LA ®)
(Non-malignant indications)

Formulary

See Amber SCG When being used for Gender Dysphoria, must only be prescribed on the advice of a specialist centre under shared care arrangement.

NB: NHS England do not recommend the use of gonadorelin analogues in children and young people for gender dysphoria. See link for further information.

 

Entry reviewed: March 2024

Leuprorelin (Prostap SR ®, Prostap 3 ®)
(Non-malignant indications)

Formulary

SeeAmber SCG When being used for Gender Dysphoria, must only be prescribed on the advice of a specialist centre under shared care arrangements.

NB: NHS England do not recommend the use of gonadorelin analogues in children and young people for gender dysphoria. See link for further information.

 

Entry reviewed: March 2024

Triptorelin (Gonapeptyl®, Decepeptyl SR®)
(Non-malignant indications)

Formulary

See Amber SCG when being used for Gender Dysphoria, must only be prescribed on the advice of a specialist centre under shared care arrangements.

NB: NHS England do not recommend the use of gonadorelin analogues in children and young people for gender dysphoria. See link for further information.

 

Entry reviewed: March 2024

 

 

Buserelin 1mg/1mL (Suprecur®)
( Injection)

RED
Restricted Drug Restricted

For the fertility clinic only

Non formulary items

Nafarelin spray (Synarel®)

 
Non Formulary

March 2022 - as per Adult Gender Identity Clinic - this product is not used. Therefore to remain Non-Formulary.

 

 

 

Entry reviewed: March 2022

06.07.02 Breast pain (mastalgia)
Classifications
May be initiated in any care setting
Specialist to advise therapy and provide first 28 days supply, continuation in Primary Care
Specialist to initiate and stabilise medicine prior to continuation in Primary Care
To be prescribed as per Shared Care Guidance. If no SCG in place status reverts to red.
Red medicines are designated as specialist only medicines which should only be prescribed by a specialist, usually within secondary care (either due to the requirement for specialist knowledge, long-term monitoring requirements, or restrictions that mean medicine supplies are only available to hospitals).
A decision has been made either locally and/or nationally not to routinely commission this preparation. Do not prescribe.
To be purchased over the counter. May be prescribed for chronic, long term conditions or on admission to hospital if essential.